Want to invest in artificial intelligence (AI), cloud computing, digital media, and e-commerce in one fell swoop? You could ...

UBS recently adjusted its price target for UnitedHealth Group from $400 to $385, citing a conservative 2025 earnings outlook ...

Health Insurance Giant’s Changing Fortunes UnitedHealth Group (NYSE:UNH) is the largest U.S. health insurer by market cap and ...

UnitedHealth's shares drop 40% in 2025 amid challenges, with mixed Q1 earnings and margin pressures ahead. Read why I rate ...

UnitedHealth is scheduled to report its Q2 earnings on July 29th. Jim Cramer recommends against buying UNH shares until then.

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” ...

Three high-profile CEO appointments underscore the evolving priorities of top organizations: The St. Louis-based health system saw its CEO, Joseph Impicciche, announce his retirement, putting the ...

Optum Rx officials said they now have eliminated reauthorization requirements for more than 140 chronic disease medications.

From new executive appointments to expanded AI tools, here are 10 updates to know on UnitedHealth Group’s Optum, the parent company of ASC chain SCA Health, that Becker’s has reported on in the first ...

Beginning on July 7, however, some hybrid employees in Minnesota, where the insurance giant is based, and Washington, D.C., ...

UnitedHealth Group’s Optum Rx will remove reauthorization requirements for more than 60 chronic disease medications on July 1.  The cuts are in addition to about 80 reauthorizations Optum Rx ...